Details for Patent: 11,845,867
Which drugs does patent 11,845,867 protect, and when does it expire?
Patent 11,845,867 protects BLUDIGO and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 11,845,867
| Title: | Process for the preparation of indigotindisulfonate sodium (indigo carmine) |
| Abstract: | This invention relates to an improved method for the preparation of highly or substantially pure Indigotindisulfonate sodium (1). It further relates to the novel crystalline form I of Indigotindisulfonate sodium (1) and the process for its preparation. |
| Inventor(s): | Manik Reddy Pullagurla, Jagadeesh Babu Rangisetty |
| Assignee: | Provepharm Life Solutions SA |
| Application Number: | US18/045,584 |
|
Patent Claim Types: see list of patent claims | Compound; Process; |
Drugs Protected by US Patent 11,845,867
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Provepharm Sas | BLUDIGO | indigotindisulfonate sodium | SOLUTION;INTRAVENOUS | 216264-001 | Jul 8, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,845,867
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3559121 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2018116325 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
